{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-157344","form_type":"8-K","ticker":null,"cik":"0001923840","company_name":"Third Harmonic Bio, Inc.","filed_at":"2024-06-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:21.225335+00:00","generated_at":"2026-06-01T05:43:02.150650+00:00","sec_items":["5.02","5.07"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"Director Rob Perez resigns from Third Harmonic Bio board; annual meeting results","bullets":["Rob Perez resigned as Class I director and as Chair of Nominating & Governance Committee, effective June 6, 2024.","Resignation not related to any disagreement over company operations, policies, or practices.","Stockholders elected Michael Gladstone and H. Martin Seidel as Class II directors for three-year terms at the annual meeting.","Deloitte & Touche LLP ratified as independent auditor for FY 2024 with 38,439,263 votes for, 1,034 against."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-157344","json":"https://secwatch.observer/filing/0001193125-24-157344.json","markdown":"https://secwatch.observer/filing/0001193125-24-157344.md","text":"https://secwatch.observer/filing/0001193125-24-157344.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1923840/000119312524157344/0001193125-24-157344-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1923840/000119312524157344/d850640d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T05:43:02.150650+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"291119f42c","claim":"Rob Perez resigned as Director at Third Harmonic Bio, Inc..","evidence_excerpt":"On June 6, 2024, Rob Perez notified the Board of Directors (the “ Board ”) of Third Harmonic Bio, Inc. (the “ Company ”) of his decision to resign as a Class I director of the Board, and as Chairperson of the Nominating and Governance Committee of the Board and a member of the Audit Committee of the Board, in each case effective as of June 6, 2024. Mr. Perez’s resignation was not related to any disagreement with the Company over any of its operations, policies, or practices.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1923840/000119312524157344/0001193125-24-157344-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}